DC
SPPI

Deere & Company’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Deere & Company’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-24,466
Closed -$149K – 1126
2015
Q1 		$149K Hold
24,466
– – 0.01% 942
2014
Q4 		$170K Hold
24,466
– – 0.01% 925
2014
Q3 		$199K Buy
+24,466
New +$191K 0.01% 885
2013
Q3 		– Sell
-23,189
Closed -$173K – 1081
2013
Q2 		$173K Buy
+23,189
New +$178K 0.01% 898

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deere & Company's SPPI Position: Q2 2015 in Review

Deere & Company sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2015, closing a stake of 24,466 shares — an estimated $149K sold.

Deere & Company first reported a position in SPPI in Q2 2013 and held it in 4 quarters. The position peaked at $199K in Q3 2014. 128 funds tracked by Wall St. Rank hold SPPI as of Q2 2015.

  • Deere & Company reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Deere & Company sold 24,466 Spectrum Pharmaceuticals Inc shares in Q2 2015, an estimated $149K.
  • Deere & Company first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Deere & Company's Spectrum Pharmaceuticals Inc position peaked at $199K in Q3 2014.
  • 128 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2015.

Based on Deere & Company's 13F filing for Q2 2015, filed 13 Aug 2015.